Chikungunya Vaccination

Chikungunya is a viral disease spread by infected mosquitoes, causing sudden high fever, severe joint pain, fatigue, and rash. While symptoms can be debilitating and long-lasting, IXCHIQ® is the first FDA-approved vaccine that helps protect against chikungunya virus.

If you’re traveling to areas where chikungunya is common—such as parts of Africa, Asia, the Caribbean, and Central and South America—one dose of IXCHIQ® can help reduce your risk of this serious illness. IXCHIQ® is a live-attenuated vaccine, approved for adults 18 years and older, however, its use has been restricted for pregnant, immunocompromised or people aged 60 and older.